by Eric Christianson | Apr 23, 2023 | Cardiovascular Case Studies, Infectious Disease and Oncology Case Studies
One thing I always encourage is critical thinking. Reviewing a diagnosis list will give you clues as to the likely medications that a patient is taking or should be taking if they are following guideline-based medication therapy. In this Bactrim CHF case study, I...
by Eric Christianson | Nov 20, 2022 | Pharmacogenomics and Pharmacokinetics Medication and Disease State Clinical Pearls
We’ve been doing some work lately to develop a chart of commonly used drugs with pharmacogenomic considerations. In anticipation of that table, I thought I’d share my top 5 medications that have pharmacogenomic considerations. If you are taking a board...
by Eric Christianson | Jun 26, 2019 | Cardiovascular Medication and Disease State Clinical Pearls, Medication and Disease State Clinical Pearls For Pharmacists
I recently did a podcast episode on heparin (which you can listen to below) and I did not mention hair loss as a potential adverse effect. In addition to heparin, it turns out there is data on other anticoagulants and this adverse effect as well. That begs the...
by Eric Christianson | May 1, 2019 | Drug Interaction Case Studies and Education For Pharmacists
One of the big advantages of newer agents like rivaroxaban is there’s less potential for diet and drug interactions than with warfarin. Now that doesn’t mean that there aren’t any rivaroxaban drug interactions. We have to pay attention to these...
by Eric Christianson | Jun 18, 2014 | Polypharmacy Cases And The Prescribing Cascade
Inevitably, several times a year, while reviewing a patient’s medications, notes, labs, etc. I will come across a lab that was drawn on an individual that is totally puzzling to me. You may see Coumadin discontinued due to various reasons, but many times it is...
